BHATT PADMANABH P. (Sr. VP of IP, CSO) sold 4.7% of their position (710.00 shares) of SUPERNUS PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $31.6K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/19/2025ACC: 0001539215-25-000008
Officer· Sr. VP of IP, CSO
Since Feb 2026
-710.00
Net shares
Net seller
$31.6K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
1.50K acquired · 2.21K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+1.50K
Price / share
—
Trade value
—
% of position
10.9%
12/18/2025
13.72K→15.22K
Common Stock
Direct
Shares
−710.00
Price / share
$44.44
Trade value
$31.55K
% of position
4.7%
12/18/2025
15.22K→14.51K
Total
Net shares
+790.00
Net value
-$31.55K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/18/2025 | M · Option Exercise | +1.50K | — | — | 10.9% | 13.72K | 15.22K |
| Common Stock Direct | 12/18/2025 | S · Sale | −710.00 | $44.44 | $31.55K | 4.7% | 15.22K | 14.51K |
| Total | +790.00 | -$31.55K | ||||||
Derivative Transactions1
Performance Share Unit
Direct
Converts to
Common Stock
1.50K shares
Shares
−1.50K
Strike price
0
Held after
0.00
Exercisable
—
12/18/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Performance Share Unit Direct | Common Stock1.50K shares | 12/18/2025 | M · Option Exercise | −1.50K | 0 | — | 0.00 |